We've noticed that you're using an ad blocker

Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.

It's off now Dismiss How do I disable my ad blocker?
❌

How to disable your ad blocker for our site:

Adblock / Adblock Plus
  • Click on the AdBlock / AdBlock Plus icon on the top right of your browser.
  • Click “Don’t run on pages on this domain.” OR “Enabled on this site.”
  • Close this help box and click "It's off now".
Firefox Tracking Prevention
  • If you are Private Browsing in Firefox, "Tracking Protection" may casue the adblock notice to show. It can be temporarily disabled by clicking the "shield" icon in the address bar.
  • Close this help box and click "It's off now".
Ghostery
  • Click the Ghostery icon on your browser.
  • In Ghostery versions < 6.0 click “Whitelist site.” in version 6.0 click “Trust site.”
  • Close this help box and click "It's off now".
uBlock / uBlock Origin
  • Click the uBlock / uBlock Origin icon on your browser.
  • Click the “power” button in the menu that appears to whitelist the current website
  • Close this help box and click "It's off now".
  • News
  • Blogs
  • Image IQ
  • Podcasts
  • Topics
  • Conferences
  • About

Modern Medicine Network
  • Login
  • Register
Skip to main content
Modern Medicine Network
  • Login
  • Register
Menu
User
Home
  • News
  • Blogs
  • Image IQ
  • Podcasts
  • Topics
  • Conferences
  • About

SUBSCRIBE: eNewsletter

Skin Cancer / Melanoma Targets

Why Are Some Patients So Sensitive?

  • Monica Key, APRN, CCRN, AOCNP
Aug 28, 2014

Many of the new treatment options for melanoma are very exciting as evidence of cancer advancement through science and clinical trials. However, we are still gathering post-market data on its associated side effects.

A Balance Between Quality Versus Quantity

  • Monica Key, APRN, CCRN, AOCNP
Aug 2, 2014

I met a young man several years ago in his thirties who was dying from metastatic melanoma. His parents were at his bedside every day at the inpatient oncology unit.

Anti-PD-1 Immunotherapy Efficacious in Metastatic Melanoma

  • Anna Azvolinsky
Jul 25, 2014

The anti-programmed-death-receptor-1 (PD-1) antibody, pembrolizumab (MK-3475), is effective and tolerable in patients with metastatic melanoma who have previously received another metastatic melanoma therapy.

The Most Common Question

  • Aaron Falchook, MD
Jul 11, 2014

What is the most common question that you are asked by patients with a new diagnosis of cancer?

Study Explains Why Anti-CTLA-4 Immunotherapy Has a Spectrum of Efficacy in Cancer Patients

  • Anna Azvolinsky
Jun 26, 2014

The immunotherapy drug ipilimumab (Yervoy) is a monoclonal antibody against CTLA-4 that is approved for treatment of metastatic melanoma patients.

Call for QOL Experiences With Targeted Therapies

  • Daniel McFarland, DO
Jun 24, 2014

Recently, we completed a review of psychological and quality of life data literature on patients receiving targeted therapies.  Very little is currently available on this topic.  The few studies that were available dealt with imatinib (or

Interim Phase III COMBI-d Results Show PFS Benefit in Patients With BRAF V600E/K Mutant Metastatic Melanoma

  • Michael Kaufman
Jun 18, 2014

CHICAGO— Interim results of the ongoing phase III COMBI-d study reported at the 2014 annual meeting of the American Society of Clinical Oncology (ASCO) show that patients with BRAF V600E/K mutant metastatic melanoma had a signifi

Ipilimumab/Nivolumab Combo Boosts Long-Term Survival in Advanced Melanoma

  • Michael Kaufman
Jun 10, 2014

Long-term results from a phase I study demonstrate that concurrent treatment with ipilimumab and nivolumab led to an unprecedented improvement in survival for patients with advanced melanoma.

Combining Immune & Targeted Therapies in Melanoma: A Paradigm for Other Tumor Types?

  • Susan Beck
Jun 6, 2014

The story of how the targeted therapies, immunotherapies, and combinations of these therapies have been developed for use in patients with advanced melanoma holds a number of important lessons for the development of agents for use in other tumor types.

Is There a Role for Intralesional Therapy in Melanoma?

  • Sarah Weiss, MD
Jun 4, 2014

On Monday during ASCO, Dr. Axel Hauschild reviewed the role of intralesional therapy in melanoma in a sub-session of the melanoma abstract review talk entitled “Evolving Utility of Intralesional Therapy for Melanoma.”

Pages

  • « first
  • ‹ previous
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • next ›
  • last »

Resource Topics rightRail

  • Resource Topics
  • Partner Content
There are currently no available Sponsored Topics
There is currently no available content. Please check back soon.
Connect with Us
  • Twitter
  • Facebook
  • RSS
Modern Medicine Network
  • Home
  • About Us
  • Advertise
  • Advertiser Terms
  • Privacy statement
  • Terms & Conditions
  • Editorial & Advertising Policy
  • Editorial Board
  • Contact Us
Modern Medicine Network
© UBM 2018, All rights reserved.
Reproduction in whole or in part is prohibited.